Control vaccine formulation - Authors' reply

Lancet. 2021 Mar 20;397(10279):1062. doi: 10.1016/S0140-6736(21)00437-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aluminum Hydroxide / administration & dosage
  • Aluminum Hydroxide / adverse effects*
  • Clinical Trials as Topic / ethics
  • Clinical Trials as Topic / standards
  • Drug Compounding / methods*
  • Humans
  • Papillomavirus Vaccines / administration & dosage
  • Papillomavirus Vaccines / adverse effects*
  • Papillomavirus Vaccines / immunology
  • Phosphates / administration & dosage
  • Phosphates / adverse effects*
  • Placebos / administration & dosage
  • Placebos / standards*
  • Societies, Scientific / standards
  • Vaccines, Combined / administration & dosage
  • Vaccines, Combined / adverse effects*
  • Vaccines, Combined / immunology

Substances

  • Papillomavirus Vaccines
  • Phosphates
  • Placebos
  • Vaccines, Combined
  • Aluminum Hydroxide
  • aluminum hydroxyphosphate sulfate